ASMTL | Acetylserotonin O-methyltransferase-like | | | | | | Expressed in all |
ASNA1 | ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial) | Transporters
| | | | | Expressed in all |
ASPH | Aspartate beta-hydroxylase | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
ATF2 | Activating transcription factor 2 | Enzymes Transcription factors
| | | | | Expressed in all |
ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP5B | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
ATP5H | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d | Mitochondrial proteins
| | | | | Expressed in all |
ATP5J | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6 | Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
BAG1 | BCL2-associated athanogene | Cancer-related genes
| | | | | Expressed in all |
BAG2 | BCL2-associated athanogene 2 | Plasma proteins
| | | | | Tissue enhanced |
BAG5 | BCL2-associated athanogene 5 | | | | | | Expressed in all |
BAIAP2 | BAI1-associated protein 2 | Plasma proteins
| | | | | Expressed in all |
BAIAP2L1 | BAI1-associated protein 2-like 1 | | | | | | Mixed |
BANP | BTG3 associated nuclear protein | | | | | | Expressed in all |
BCAP31 | B-cell receptor-associated protein 31 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted secreted proteins
| | | | | Mixed |
BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Mixed |
BCL9L | B-cell CLL/lymphoma 9-like | | | | | | Expressed in all |
BCLAF1 | BCL2-associated transcription factor 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
BID | BH3 interacting domain death agonist | Mitochondrial proteins
| | | | | Expressed in all |
BIN1 | Bridging integrator 1 | Disease related genes
| | | | | Tissue enriched |
BIRC5 | Baculoviral IAP repeat containing 5 | Cancer-related genes
| | | | | Mixed |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
BMP2K | BMP2 inducible kinase | Enzymes
| | | | | Expressed in all |
BTF3 | Basic transcription factor 3 | Plasma proteins
| | | | | Expressed in all |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
BUB3 | BUB3 mitotic checkpoint protein | | | | | | Expressed in all |
C11orf30 | Chromosome 11 open reading frame 30 | Plasma proteins
| | | | | Expressed in all |
C17orf70 | Chromosome 17 open reading frame 70 | | | | | | Expressed in all |
C1orf198 | Chromosome 1 open reading frame 198 | Predicted secreted proteins
| | | | | Expressed in all |
C20orf112 | Chromosome 20 open reading frame 112 | | | | | | Expressed in all |
C21orf33 | Chromosome 21 open reading frame 33 | Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
C8orf58 | Chromosome 8 open reading frame 58 | | | | | | Expressed in all |
C9orf78 | Chromosome 9 open reading frame 78 | | | | | | Expressed in all |
CALD1 | Caldesmon 1 | Cytoskeleton related proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CALU | Calumenin | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CAPG | Capping protein (actin filament), gelsolin-like | Plasma proteins
| | | | | Expressed in all |
CAPN1 | Calpain 1, (mu/I) large subunit | Enzymes Plasma proteins
| | | | | Expressed in all |
CAPN2 | Calpain 2, (m/II) large subunit | Enzymes Plasma proteins
| | | | | Expressed in all |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
CASP3 | Caspase 3, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CASP6 | Caspase 6, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes
| | | | | Expressed in all |
CAST | Calpastatin | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CBR3 | Carbonyl reductase 3 | Enzymes
| | | | | Mixed |